{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:58:03Z","timestamp":1791356283493,"version":"4.3.1"},"reference-count":23,"publisher":"Impact Journals, LLC","issue":"49","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,12,6]]},"DOI":"10.18632\/oncotarget.13019","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T21:41:44Z","timestamp":1478122904000},"page":"80655-80663","source":"Crossref","is-referenced-by-count":38,"title":["<i>ERBB2<\/i> mutation is associated with a worse prognosis in patients with <i>CDH1<\/i> altered invasive lobular cancer of the breast"],"prefix":"10.18632","volume":"7","author":[{"given":"Zheng","family":"Ping","sequence":"first","affiliation":[{"name":"Division of Anatomic Pathology, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene P.","family":"Siegal","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology, University of Alabama at Birmingham, Birmingham, AL, USA"},{"name":"UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuko","family":"Harada","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology, University of Alabama at Birmingham, Birmingham, AL, USA"},{"name":"UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isam-Eldin","family":"Eltoum","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology, University of Alabama at Birmingham, Birmingham, AL, USA"},{"name":"UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Youssef","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiansheng","family":"Shen","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbo","family":"He","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Huang","sequence":"additional","affiliation":[{"name":"Ningbo Clinical and Pathological Diagnosis Center, Ningbo, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongquan","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Preventive Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA"},{"name":"UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Li","sequence":"additional","affiliation":[{"name":"Division of Cell and Molecular Pathology, Departments of Pathology, University of Alabama at Birmingham, Birmingham, AL, USA"},{"name":"UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirby I","family":"Bland","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA"},{"name":"UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena R","family":"Chang","sequence":"additional","affiliation":[{"name":"Revlon\/UCLA Breast Center, Department of Surgery, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejun","family":"Shen","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology, University of Alabama at Birmingham, Birmingham, AL, USA"},{"name":"UAB Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,11,2]]},"reference":[{"key":"1","volume-title":"WHO Classification of Tumours of the Breast","author":"van de Vijver","year":"2012","edition":"4th ed"},{"key":"2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13058-015-0519-x","article-title":"Invasive lobular carcinoma of the breast: morphology, biomarkers and 'omics","volume":"17","author":"Simpson","year":"2015","journal-title":"Breast Cancer Res"},{"key":"3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.critrevonc.2014.07.003","article-title":"Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions?","volume":"92","author":"Fiche","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s10549-012-2002-z","article-title":"Invasive lobular breast cancer: subtypes and outcome","volume":"133","author":"Colleoni","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/bs.ctdb.2014.12.001","article-title":"Adhesion in mammary development: novel roles for E-cadherin in individual and collective cell migration","volume":"112","author":"Ewald","year":"2015","journal-title":"Curr Top Dev Biol"},{"key":"6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0b013e3182918a2b","article-title":"Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry","volume":"37","author":"Richardson","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"7","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/PAS.0b013e3181f01916","article-title":"Clinical and biological significance of E-cadherin protein expression in invasive lobular carcinoma of the breast","volume":"34","author":"Ellis","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ijc.10176","article-title":"CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk","volume":"98","author":"Vorechovsk\u00fd","year":"2002","journal-title":"Int J Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","article-title":"TCGA Research Network, Perou CM. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer","volume":"163","author":"Hayat","year":"2015","journal-title":"Cell"},{"key":"10","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1200\/JCO.2015.64.0334","article-title":"Genomic Characterization of Primary Invasive Lobular Breast Cancer","volume":"34","author":"Majjaj","year":"2016","journal-title":"J Clin Oncol"},{"key":"11","doi-asserted-by":"crossref","first-page":"18517","DOI":"10.1038\/srep18517","article-title":"Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer","volume":"6","author":"He","year":"2016","journal-title":"Sci Rep"},{"key":"12","doi-asserted-by":"crossref","first-page":"27545","DOI":"10.1038\/srep27545","article-title":"A microscopic landscape of the invasive breast cancer genome","volume":"6","author":"Shen","year":"2016","journal-title":"Sci Rep"},{"key":"13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/2153-3539.126147","article-title":"Mining genome sequencing data to identify the genomic features linked to breast cancer histopathology","volume":"5","author":"Shen","year":"2014","journal-title":"J Pathol Inform"},{"key":"14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10549-015-3336-0","article-title":"Frequent alterations of HER2 through mutation, amplification, or overexpression in pleomorphic lobular carcinoma of the breast","volume":"150","author":"Jeng","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"15","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.6004\/jnccn.2015.0131","article-title":"HER2-Mutated Breast Cancer Responds to Treatment With Single-Agent Neratinib, a Second-Generation HER2\/EGFR Tyrosine Kinase Inhibitor","volume":"13","author":"Ellis","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"16","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/ng.2762","article-title":"Emerging landscape of oncogenic signatures across human cancers","volume":"45","author":"Sander","year":"2013","journal-title":"Nat Genet"},{"key":"17","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1101\/gad.279190.116","article-title":"Modeling invasive lobular breast carcinoma by CRISPR\/Cas9-mediated somatic genome editing of the mammary gland","volume":"30","author":"Boelens","year":"2016","journal-title":"Genes Dev"},{"key":"18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1158\/2159-8290.CD-12-0349","article-title":"Activating HER2 mutations in HER2 gene amplification negative breast cancer","volume":"3","author":"Mardis","year":"2013","journal-title":"Cancer Discov"},{"key":"19","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1158\/1078-0432.CCR-13-0295","article-title":"Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutations","volume":"19","author":"Palmer","year":"2013","journal-title":"Clin Cancer Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/cncr.30102","article-title":"Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies","volume":"122","author":"Waintraub","year":"2016","journal-title":"Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1158\/1078-0432.CCR-07-4367","article-title":"EXEL-7647 inhibits mutant forms of ErbB2 associated with lapatinib resistance and neoplastic transformation","volume":"14","author":"Gerritsen","year":"2008","journal-title":"Clin Cancer Res"},{"key":"22","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/17425255.2016.1198317","article-title":"Pharmacodynamics, pharmacokinetics and clinical efficacy of neratinib in HER2-positive breast cancer and breast cancer with HER2 mutations","volume":"12","author":"Awada","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"23","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1470-2045(15)00551-3","article-title":"ExteNET Study Group. Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"Mansi","year":"2016","journal-title":"Lancet Oncol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T13:12:08Z","timestamp":1596719528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.13019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,2]]},"references-count":23,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2016,12,6]]}},"alternative-id":["13019","27811364"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.13019","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,2]]}}}